States Tout Proposed $26B Agreement With J&J, Opioid Distributors

By Beth Wang / July 21, 2021 at 6:55 PM
Attorneys general from 14 states on Wednesday (July 21) touted their proposed $26 billion opioid settlement under which drug maker Johnson & Johnson will be prohibited from selling opioids, and three of the nation’s largest drug distributors will be required to put in place processes for monitoring opioid distribution and flagging suspicious orders. The proposal aims to resolve states’ claims against J&J and drug distributors McKesson Corporation, Cardinal Health and AmerisourceBergen for their roles in creating and fueling the opioid...

Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.